Your Navigation:PCAR > Abstract
Search pcar
检索项:
检索词:
Abstract
Pharmaceutical Care and Research: 2018; 18(6):439-443
DOI: 10.5428/pcar20180611
Analysis and experience of clinical pharmacists participating in drug treatment of invasive fungal diseases
1. YU Li(Department of Pharmacy,7th People’s Hospital of Zhengzhou,He’nan Province,Zhengzhou 450016,China yuli2008101@126.com)
2. ZHANG HanJuan(Department of Pharmacy,7th People’s Hospital of Zhengzhou,He’nan Province,Zhengzhou 450016,China )
3. YUAN DongDong(Department of Pharmacy,7th People’s Hospital of Zhengzhou,He’nan Province,Zhengzhou 450016,China )
4. CHEN YongYan(Department of Pharmacy,7th People’s Hospital of Zhengzhou,He’nan Province,Zhengzhou 450016,China )
5. YANG YuLing(Department of Pharmacy,7th People’s Hospital of Zhengzhou,He’nan Province,Zhengzhou 450016,China )
ABSTRACT  Objective: To summarize the experience of clinical pharmacists involved in the drug treatment of invasive fungal diseases.Methods: Three cases of invasive fungal diseases (including Candidemia,Candida urinary tract infection and invasive pulmonary aspergillosis) with clinical pharmacists involved in the drug treatment were analyzed, and clinical thinking and entry point of pharmaceutical care with direct involvement of pharmacists were elaborated and analyzed statistically.Results: By using professional knowledge,clinical pharmacists helped physicians to optimize drug treatment regimen and good results were achieved. Conclusion: Direct involvement of clinical pharmacists could improve treatment of invasive fungal diseases and reduce the incidence of related adverse drug reactions.
Welcome to PCAR! You are the number 231 reader of this article!
Please cite this article as:
YU Li,ZHANG HanJuan,YUAN DongDong,CHEN YongYan,YANG YuLing,. Analysis and experience of clinical pharmacists participating in drug treatment of invasive fungal diseases[J]. Pharmaceutical Care and Research / yao xue fu wu yu yan jiu. 2018; 18(6): 439-443.
References:
1. LI Meng,LIAO WanQing.Advances in the treatment of invasive fungal infections[J].Chin J Mycol,2012,7(1):47-51.In Chinese with English abstract.
2. Expert Group of Candidiasis Diagnosis and Treatment Strategy Summit Forum of Chinese Medical Assocication.The diagnosis and treatment of Candidiasis: expert consensus[J].Chin J Infect Chemother,2011,11(2):81-95.In Chinese with English abstract.
3. YUAN LiLi,LI GuangHui.Clinical practice guidelines for the management of candidiasis:2016 update by the Infectious Diseases Society of America[J].Chin J Infect Chemother,2016,16(4):521-528.In Chinese with English title.
4. XIA Di,SHI Yi.Pharmacokinetics and pharmacodynamics of echinocandins for optimizing regimen in clinical practice[J].Chin J Infect Chemother,2015,15(4):383-386.In Chinese with English title.
5. MEI HeKun,WANG Dong,BAI Nan,et al.Bibliometric analysis of research papers of amphotericin B nephrotoxicity[J].Chin J New Drugs Clin Rem,2014,33(12):924-928.In Chinese with English abstract.
6. LIU XiaoDong,LI JiaNan,SUN Hao,et al.Literature analysis of adverse drug reactions of amphotericin B and amphotericin B liposome[J].Chin J Clin Pharm,2014,23(4):252-255.In Chinese.
7. LIU Rong,LU XiaLin,DONG Ping.Study on the compatible stability of amphotericin B for injection and 5% glucose injection from different manufacturers[J].China Pharmacy,2015,26(20):2771-2773.In Chinese with English abstract.
8. ZHOU MengLan,XU YingChun,ZHAO YuPei.Advances in serological detection of invasive fungal diseases[J].Chin J Infect Chemother,2018,18(1):118-123.In Chinese with English abstract.
9. TANG XiaoDan,LI GuangHui.The interpretation of practice guidelines for the diagnosis and management of aspergillosis:2016 update by the Infectious Diseases Society of America[J].Chin J Infect Chemother,2017,17(4):456-462.In Chinese with English title.
10. WANG YuFan,LIU ShuYe.Recent advances in the resistance mechanisms and treatment strategy for Candida species resistant to amphotericin B[J].Chin J Antibiot,2014,39(9):706-714.In Chinese with English abstract.
《药学服务与研究》杂志社 All Rights Reserved 网站备案号:鲁B2-20061008
·地址:上海市杨浦区长海路168号18号楼东三楼 邮政编码:200433
·联系电话(传真):86-21-65519829, 021-31162330
·电子邮件:PharmCR@vip.163.com
·技术支持:中国康网
管理员入口